Monthly Archives: February 2024

Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) Drug alert number: EL (24)A/04 Date issued: 01 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Gepretix 100mg Capsules (Exeltis UK Limited) Company name: Exeltis UK Limited Product name: Gepretix 100mg Capsules, [...]

The post MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) appeared first on Community Pharmacy England.

This week the MHRA has issued new safety and educational materials for patients and healthcare professionals to support the implementation of the new regulatory measures. These materials include: Updated Patient Guide Updated Healthcare Professional Guide Updated Annual Risk Acknowledgement Form New Risk Acknowledgment Form for male patients starting valproate Patient Card Pharmacy Poster Warning Stickers [...]

The post MHRA issues new materials for valproate safety measures appeared first on Community Pharmacy England.

The following price concessions granted in January 2024 have rolled over to February 2024: Drug Pack size Price concession Baclofen 10mg tablets 84 £1.99 Benzydamine 0.15% mouthwash sugar free 300 £4.79 Carbocisteine 250mg/5ml oral solution 300 £7.49 Co-careldopa 12.5mg/50mg tablets 90 £4.26 Flucloxacillin 500mg capsules 28 £2.41 Lansoprazole 30mg gastro-resistant capsules 28 £1.30 Pregabalin 200mg [...]

The post Rolled over price concessions for January 2024 appeared first on Community Pharmacy England.